These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29792526)

  • 21. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage therapy: a regulatory perspective.
    Pelfrene E; Willebrand E; Cavaleiro Sanches A; Sebris Z; Cavaleri M
    J Antimicrob Chemother; 2016 Aug; 71(8):2071-4. PubMed ID: 27068400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steering Phages to Combat Bacterial Pathogens.
    Gurney J; Brown SP; Kaltz O; Hochberg ME
    Trends Microbiol; 2020 Feb; 28(2):85-94. PubMed ID: 31744662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Wake-Up Call: We Need Phage Therapy Now.
    Moelling K; Broecker F; Willy C
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy for severe bacterial infections: a narrative review.
    Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
    Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring bacteriophage therapy for drug-resistant bacterial infections.
    Schooley RT
    Top Antivir Med; 2023 Mar; 31(1):23-30. PubMed ID: 37018733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage therapy: delivering on the promise.
    Harper DR; Anderson J; Enright MC
    Ther Deliv; 2011 Jul; 2(7):935-47. PubMed ID: 22833904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophages and its applications: an overview.
    Sharma S; Chatterjee S; Datta S; Prasad R; Dubey D; Prasad RK; Vairale MG
    Folia Microbiol (Praha); 2017 Jan; 62(1):17-55. PubMed ID: 27718043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.
    Rohde C; Resch G; Pirnay JP; Blasdel BG; Debarbieux L; Gelman D; Górski A; Hazan R; Huys I; Kakabadze E; Łobocka M; Maestri A; Almeida GMF; Makalatia K; Malik DJ; Mašlaňová I; Merabishvili M; Pantucek R; Rose T; Štveráková D; Van Raemdonck H; Verbeken G; Chanishvili N
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29621199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage Therapy Takes on Broad Applications.
    Mertz L
    IEEE Pulse; 2022; 13(5):9-15. PubMed ID: 36301810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage-mediated modulation of microbiota for diseases treatment.
    Zhang Y; Li CX; Zhang XZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113856. PubMed ID: 34237403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the Immune Response to Phage Therapy.
    Krut O; Bekeredjian-Ding I
    J Immunol; 2018 May; 200(9):3037-3044. PubMed ID: 29685950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.